Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Member sign in
Join redeye
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
The latest from Redeye about Scandinavian Life Science and Technology companies
Investor Forum
Repris av bolagspresentationer (A1M, XMReality, IMINT)
Premium
Medivir
Under radarn
G5 Entertainment
We expect a stable quarter
Ascelia Pharma
Sammanfattning av caset
Immunicum
Immunicum: Interview with CEO Carlos de Sousa
Ascelia Pharma
Öppnar upp för en ny marknad
Christian Berner Tech Trade
Q3’19 Preview
Enea
Q3’19 preview: Expected EBIT growth of 31%
ProAct IT Group
Acquires PeopleWare
Premium
Top Picks:
Värdeskapande framsteg
Cimco Marine
Funding secured
Medivir
Birinapant enters a new indication
Gaming Innovation Group
3 key questions to Chairman Petter Nylander
ProAct IT Group
Preview Q3’19
Transactions
04
Oct
Cimco Marine nyttjandeperiod för teckningsoptioner pågår till och med 17 oktober 2019
09
Oct
Acarix genomför företrädesemission
Events
24
Oct
Investor After Work Göteborg
05
Nov
Aspire Global Live-Q 5 Nov
05
Nov
Enlabs Live-Q 5 Nov
05
Nov
Investor Forum
07
Nov
Investor After Work Malmö
14
Nov
Investor After Work Göteborg
Announcements
Redeye söker Projektledare inom Corporate Finance
Vill du bli vår IT-support?
New accounting principle to affect upcoming interim reports